Skip to main content
Tech.euFundingExplorerBeta

Norgine

Exited

Specialty pharmaceutical company

Norgine is tracked in the Tech.eu funding database. Based in Amsterdam, Netherlands; active in Healthtech. Acquired by Goldman Sachs in 2022. Data as of Nov 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Jun 2022
Value
€1.8B
Acquiror
Goldman Sachs (United States of America)

Similar companies

same sector, similar size

Global coverage: FundingData